Back to Results
Vaibhav Kumar, MD, MRCP
Department + Services
Institute for Clinical Research and Health Policy Studies (ICRHPS), Predictive Analytics and Comparative Effectiveness (PACE) Center
|Programs + Specialties
||Cancer screening, cost effective analysis, predictive modelling
|Training + Education
Imperial College School of Medicine, London; Tufts Medical Center
2016, Senior Resident of the Year,Tufts Medical Center
2016, Emergency Medicine Resident of the Year, Tufts Medical Center
2013, Grand Round Presentation Winner, Manchester Royal Infirmary, UK
2009, Faculty of Medicine Award, Overall Performance in Medical Finals, Imperial, UK
2008, Sturges Prize, Microbiology, Imperial, UK
1. Kumar V, Santhanakrishnan K. Obstructing Broncholith. Lancet. 2013; 382(9903):1534.
2. Charron CE, Chou PC, Coutts DJC, Kumar V, To M, Akashi K, Barnes PJ, Ito K. Hypoxia-inducible Factor 1 alpha Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription. J BIOL CHEM. 2009; 284:36047-36054.
3. Kumar V, Charron CE, Barnes PJ, Ito K. Hypoxia decreases HDAC2 in U937 cells as a possible mechanism for glucocorticoid resistance in COPD. Thorax 2007; 62(suppl3):A27.
Vaibhav Kumar, MD, MRCP is originally from the United Kingdom and completed his medical school training at Imperial College London. After gaining membership to the Royal College of Physicians, Dr. Kumar moved to Boston to complete his residency at Tufts Medical Center. As an aspirational academic oncologist, he is a strong advocate for evidence-based cancer screening. Dr. Kumar's current interests lie in improving the efficiency and cost-effectiveness in the lung cancer screening process.
In his spare time, Dr. Kumar enjoys running and participates annually in either the BAA 10K or Half Marathon. He also enjoys playing golf, badminton and tennis.